Does co-treatment with retinyl retinoate and a PPARα agonist reduce retinoid dermatitis?
  Our results indicate that PPARα agonists can potentially be used to improve retinoid dermatitis. We suggest that co-treatment with retinyl retinoate and a PPARα agonist may reduce or prevent detrimental alterations in retinoid-treated skin.
All these compounds are obtained from this plant for the first time.